Liposomal quercetin: evaluating drug deliveryin vitroand biodistributionin vivo

Manipulation of adenovirus interactions with host factors for gene therapy applications

(2012) Margaret R Duffy et al.   Nanomedicine

The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ɛ-caprolactone) nanoparticles

(2011) Hongliang Xin et al.   BIOMATERIALS

Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation

(2011) Cristina P. R. Xavier et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics

(2011) Bart J. Crielaard et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Development of Nanosuspension Formulation for Oral Delivery of Quercetin

(2011) Min Sun et al.   Journal of Biomedical Nanotechnology

Cocrystals of Quercetin with Improved Solubility and Oral Bioavailability

(2011) Adam J. Smith et al.   MOLECULAR PHARMACEUTICS

Experimental Anticancer Therapy with Vascular-disruptive Peptide and Liposome-entrapped Chemotherapeutic Agent

(2010) Aleksander Sochanik et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes

(2010) Hiroyuki Koide et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Enhanced Stability and Intracellular Accumulation of Quercetin by Protection of the Chemically or Metabolically Susceptible Hydroxyl Groups with a Pivaloxymethyl (POM) Promoiety

(2010) Mi Kyoung Kim et al.   JOURNAL OF MEDICINAL CHEMISTRY

Preparation and Characterization of Quercetin Nanocrystals

(2010) N.G. Sahoo et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Infrared Spectroscopy Reveals the Nonsynchronicity Phenomenon in the Glassy to Fluid Micellar Transition of DSPE-PEG2000 Aqueous Dispersions

(2010) Fu-Gen Wu et al.   LANGMUIR

Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors

(2009) Esben K. U. Larsen et al.   ACS Nano

Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs

(2009) Kunikazu Moribe et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

(2009) Tsutomu Ishihara et al.   PHARMACEUTICAL RESEARCH

Liposomes: Technologies and Analytical Applications

(2008) Aldo Jesorka et al.   Annual Review of Analytical Chemistry

Quercetin in w/o microemulsion: In vitro and in vivo skin penetration and efficacy against UVB-induced skin damages evaluated in vivo

(2008) F VICENTINI et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Biofunctionalized targeted nanoparticles for therapeutic applications

(2008) Andrew Z Wang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Advances in PEGylation of important biotech molecules: delivery aspects

(2008) Sinéad M Ryan et al.   Expert Opinion on Drug Delivery

Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles

(2008) HouLi Li et al.   JOURNAL OF CONTROLLED RELEASE

Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells

(2008) Enrico Lugli et al.   LEUKEMIA RESEARCH

Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats

(2008) Aparajita Ghosh et al.   LIFE SCIENCES

Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations

(2007) C.M. O'Driscoll et al.   ADVANCED DRUG DELIVERY REVIEWS

Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles

(2007) Tzu-Hui Wu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS